Early research (Phase 1)Ended earlyNCT04735796What this trial is testingStudy of LM-102 in Subjects in Advanced TumorsWho this might be right forAdvanced Solid Tumors LaNova Medicines Limited 9
Early research (Phase 1)Study completedNCT05990920What this trial is testingStudy of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional TherapyWho this might be right forPathologically Confirmed Cancer Refractory to Conventional TherapyRefractory CancerMetastatic Cancer+5 more NKGen Biotech, Inc. 6
Early research (Phase 1)Study completedNCT05525780What this trial is testingDose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Donepezil From Single Dose of GB-5001 IM Depot and Aricept® Oral Tablets in Healthy Male VolunteersWho this might be right forAlzheimer Disease G2GBio, Inc. 48
Early research (Phase 1)Study completedNCT01454986What this trial is testingStudy to Evaluate Safety, Tolerability, PK and PD of ALXN1007 in Healthy SubjectsWho this might be right forHealthy Alexion Pharmaceuticals, Inc. 64
Testing effectiveness (Phase 2)Looking for participantsNCT04588922What this trial is testingStudy of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AMLWho this might be right forHematologic Malignancies Sellas Life Sciences Group 160
Early research (Phase 1)Ended earlyNCT03809624What this trial is testingStudy of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck CancerWho this might be right forMetastatic Solid TumorsNon-small Cell Lung CancerMelanoma+6 more Inhibrx Biosciences, Inc 160
Early research (Phase 1)Study completedNCT03063762What this trial is testingStudy to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC)Who this might be right forRenal Cell Carcinoma Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Study completedNCT05630573What this trial is testingTNM001 in Chinese Healthy Preterm and Term InfantsWho this might be right forRespiratory Syncytial Virus Infections Zhuhai Trinomab Pharmaceutical Co., Ltd. 31
Early research (Phase 1)Ended earlyNCT02931110What this trial is testingStudy of IV CBL0137 in Previously Treated Hematological SubjectsWho this might be right forHematological Malignancies Incuron 5
Testing effectiveness (Phase 2)Ended earlyNCT02431260What this trial is testingAn Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesWho this might be right forSolid Tumors and Hematologic Malignancy Incyte Corporation 69
Early research (Phase 1)WithdrawnNCT02953496What this trial is testingSafety/ Feasibility of Percutaneous Administration of Vonapanitase as Monotherapy for Peripheral Artery Disease (PAD) of the SFA and Popliteal ArteriesWho this might be right forPeripheral Artery Disease Proteon Therapeutics
Testing effectiveness (Phase 2)Looking for participantsNCT07181161What this trial is testingStudy of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate CancerWho this might be right forMetastatic Prostate Cancer AstraZeneca 283
Testing effectiveness (Phase 2)Study completedNCT03773042What this trial is testingA Study Evaluating Tolerability, Efficacy, and Safety of HSK3486 Injectable Emulsion in PatientsWho this might be right forColonoscopy Sichuan Haisco Pharmaceutical Group Co., Ltd 64
Testing effectiveness (Phase 2)Study completedNCT01812642What this trial is testingA Pharmacokinetics Study to Evaluate Safety and Tolerability of JNJ-37822681 in Participants With Stable SchizophreniaWho this might be right forSchizophrenia Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 33
Early research (Phase 1)Study completedNCT00052273What this trial is testingLY317615 Plus Capecitabine in Treating Patients With Advanced Solid TumorsWho this might be right forAdultSolid Tumor Jonsson Comprehensive Cancer Center 16
Early research (Phase 1)Study completedNCT03029455What this trial is testingEvaluate Safety and Pharmacokinetics of VX-659 in Healthy Subjects and in Adults With Cystic FibrosisWho this might be right forCystic Fibrosis Vertex Pharmaceuticals Incorporated 163
Early research (Phase 1)Study completedNCT06394167What this trial is testingDose Escalation Study of Intravenous VX-993 in Healthy AdultsWho this might be right forPain Vertex Pharmaceuticals Incorporated 88
Early research (Phase 1)Study completedNCT02291471What this trial is testingTolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese VolunteersWho this might be right forRheumatic Diseases Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 56
Early research (Phase 1)Looking for participantsNCT05885412What this trial is testingA Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)Who this might be right forPKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM) Rocket Pharmaceuticals Inc. 9
Testing effectiveness (Phase 2)Temporarily pausedNCT05961007What this trial is testingEvaluation of IBI302 Injection in nAMD or DMEWho this might be right forNeovascular Age-related Macular DegenerationDiabetic Macular Edema Innovent Biologics (Suzhou) Co. Ltd. 234